Zhitong Pharmaceutical and Wahyong Instrument Sign a Strategic Cooperation Agreement

Date:


On September 16, 2022, Shanghai Zhitong Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Zhitong Pharmaceutical) and Shenzhen Wahyong Analysis Instrument Co., Ltd. (hereinafter referred to as Huarong Instrument) signed a strategic cooperation agreement in Shanghai. Based on the principles of sincere cooperation, mutual benefit, and common development, both parties have established the "Complex Drug Dissolution Test Technology Demonstration Laboratory" and officially launched it at Zhitong Pharmaceutical.

The joint construction of the laboratory is a further deepening of cooperation between the two sides in the field of complex drug dissolution technology; At the same time, the cooperative laboratory will serve as a platform and link, becoming a base for continuous exploration and accumulation of experience, contributing to promoting drug innovation and promoting the development of the pharmaceutical industry in China.

Zhitong Pharmaceutical and Wahyong Instrument Sign a Strategic Cooperation Agreement

Zhitong Pharmaceutical, founded in 2010, is located in the core area of the "Medicine Valley" of Zhangjiang High tech Park. It is a company that provides customized services to Chinese pharmaceutical peers. The company is committed to providing professional pharmaceutical formulation development services for the pharmaceutical industry, adhering to and developing high-end and advanced formulation technology. At present, the business covers the entire cycle of drug development, including product initiation research and risk assessment, formulation development, analysis method development and validation, pilot scale up and technology transfer, clinical trial (strategic joint license) registration and application, and other complete drug development processes. Since the establishment of the company, the multi particle drug delivery system (pellets) technology platform has successfully incubated multiple products. Through a series of project development practices, the focus has been on developing a drug solubilization technology platform with hot melt extrusion (HME) as the core, as well as a children's friendly dosage form technology platform characterized by powder uncoated and fine-grained formulations. Through the development of advanced pharmaceutical technology mentioned above, Zhitong Pharmaceutical has always been at the forefront of high-end pharmaceutical technology in China, with a continuous stream of innovative capabilities.

Wahyong Instrument is a national high-tech enterprise specializing in the research and development, production, and sales of equipment for drug testing and laboratory pre-treatment. Our products cover fully automatic sampling and dissolution instruments, reciprocating cylinder dissolution instruments, flow cell dissolution instruments, transdermal diffusion systems, etc. We have over 40 independent intellectual property rights such as utility model patents, appearance patents, software copyrights, etc. We comply with USP and CHP standards and have passed ISO9001:2015 quality management system certification. At the same time, it also provides users with high-quality pre-sales and after-sales service and application support.

Zhitong Pharmaceutical and Wahyong Instrument Sign a Strategic Cooperation Agreement